Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding. 2010

Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
Nerviano Medical Sciences Srl, Business Unit Oncology, Viale Pasteur 10, 20014 Nerviano, MI, Italy. maria.menichincheri@nervianoms.com

Cdc7 serine/threonine kinase is a key regulator of DNA synthesis in eukaryotic organisms. Cdc7 inhibition through siRNA or prototype small molecules causes p53 independent apoptosis in tumor cells while reversibly arresting cell cycle progression in primary fibroblasts. This implies that Cdc7 kinase could be considered a potential target for anticancer therapy. We previously reported that pyrrolopyridinones (e.g., 1) are potent and selective inhibitors of Cdc7 kinase, with good cellular potency and in vitro ADME properties but with suboptimal pharmacokinetic profiles. Here we report on a new chemical class of 5-heteroaryl-3-carboxamido-2-substituted pyrroles (1A) that offers advantages of chemistry diversification and synthetic simplification. This work led to the identification of compound 18, with biochemical data and ADME profile similar to those of compound 1 but characterized by superior efficacy in an in vivo model. Derivative 18 represents a new lead compound worthy of further investigation toward the ultimate goal of identifying a clinical candidate.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
January 2009, Journal of medicinal chemistry,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
February 2008, Journal of medicinal chemistry,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
June 2004, Journal of medicinal chemistry,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
November 1983, Journal of medicinal chemistry,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
April 2005, Journal of medicinal chemistry,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
September 1984, Bollettino chimico farmaceutico,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
January 2012, The open medicinal chemistry journal,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
January 1971, Journal of pharmaceutical sciences,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
April 2020, Archiv der Pharmazie,
Maria Menichincheri, and Clara Albanese, and Cristina Alli, and Dario Ballinari, and Alberto Bargiotti, and Marina Caldarelli, and Antonella Ciavolella, and Alessandra Cirla, and Maristella Colombo, and Francesco Colotta, and Valter Croci, and Roberto D'Alessio, and Matteo D'Anello, and Antonella Ermoli, and Francesco Fiorentini, and Barbara Forte, and Arturo Galvani, and Patrizia Giordano, and Antonella Isacchi, and Katia Martina, and Antonio Molinari, and Jürgen K Moll, and Alessia Montagnoli, and Paolo Orsini, and Fabrizio Orzi, and Enrico Pesenti, and Antonio Pillan, and Fulvia Roletto, and Alessandra Scolaro, and Marco Tatò, and Marcellino Tibolla, and Barbara Valsasina, and Mario Varasi, and Paola Vianello, and Daniele Volpi, and Corrado Santocanale, and Ermes Vanotti
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!